Medinteract’s COGselftest™ to be deployed through Summit Medical Group to improve early identification of cognitive impairment, including Alzheimer’s disease
Knoxville, TN – November 5, 2012 – Medical Interactive Education, LLC (Medinteract), a cognitive wellness company, and Summit Medical Group, a leading primary care provider, announced today that the Medinteract COGselftest (CST™) will begin to rollout in [...]
Medinteract’s co-founder, Dr. John Dougherty and Dr. Alan Solomon from the University of Tennessee Medical Center, discuss the exciting research collaboration with Eli Lilly and Co. and the newly FDA-approved Amyvid which is used in the early diagnosis of mild cognitive impairment (MCI) and early Alzheimer’s disease.
Dr. Monica Crane, one of our advising physicians, recently spoke with WATE News about Pat Summitt’s impact on the Alzheimer’s community. http://www.wate.com/story/17538659/geriatric-specialist-discusses-pat-summitts-impact-on-the-alzheimers-community